🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, placebo-controlled study of the influenza va...
Status
Completed
Location
Clinical and Translation Research Center
Start Date
2022-10-17
Trial ID
NCT05654441
Treatments Being Tested
To evaluate the bacterial-viral interactions between LPS and Fluenz as a mo...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02642237
Background: Influenza A H3N2 is a flu virus. Symptoms include fever, cough...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2015-10-31
Trial ID
NCT02594189
Treatments Being Tested
Respiratory viruses including influenza and respiratory syncytial virus (RS...
Status
Completed
Location
National Heart and Lung Institute, Imperial College London
Start Date
2012-04
Trial ID
NCT02755948
The purpose of this study are to determine the effect FF-3 in comparison to...
Status
Completed
Location
Quintiles Drug Research Unit
Start Date
2015-09
Trial ID
NCT02423577
Treatments Being Tested
The study will characterise Influenza A/Perth/16/2009(H3N2) virus in health...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02525055
This protocol tests whether changes in BLyS or IFN can be detected in a nor...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-10
Trial ID
NCT00611611
Annual influenza vaccination is recommended in patients with systemic lupus...
Status
Completed
Location
CIC Vaccinologie Hopital Cochin
Start Date
2009-09
Trial ID
NCT01072734
Treatments Being Tested
This study examines how the immune system responds to the flu virus (H3N2) ...
Status
Recruiting
Location
Hope Clinic
Start Date
2022-05-24
Trial ID
NCT05332899
Treatments Being Tested
This is a non-controlled, open-label, single-centre, dose-escalation study ...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-02
Trial ID
NCT04372719
Treatments Being Tested